Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a New Istaroxime Patent

Windtree Therapeutics, Inc. reported that the United States Patent and Trademark Office has issued a Notice of Allowance of new patent claims for istaroxime administration.